Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Pascal Maisonobe

110. Factors influencing goal attainment in patients with poststroke upper limb spasticity following treatment with botulinum neurotoxin A in real-life clinical practice: subanalyses from the Upper Limb International Spasticity (ULIS)-II Study

scholarly article by Jorge Jacinto et al published January 2015 in Toxicon

A 500 U/2 mL dilution of abobotulinumtoxinA vs. placebo: randomized study in cervical dystonia

scientific article published on 17 January 2018

A comparison of goal selection and achievement according to patient sex in the upper limb international spasticity (ULIS)-Ii study

scholarly article by Svetlana Khatkova et al published December 2016 in Toxicon

A comparison of goal selection and achievement between botulinum toxin A (BoNT-A) naïve and non-naïve patients in the upper limb international spasticity (ULIS)-II study

scholarly article by Christina Marciniak et al published December 2016 in Toxicon

A prospective, observational grouped analysis to evaluate the effect of triptorelin on lower urinary tract symptoms in patients with advanced prostate cancer

scientific article published on June 2015

Abobotulinumtoxina injections in shoulder muscles for adult upper limb spasticity: Results from a phase 4 real-world study and a phase 3 open-label trial

scientific article published on 25 May 2020

Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study ⬇️

scientific article published on September 20, 2013

Botulinum Toxin Injection for Hypertonicity of the Upper Extremity Within 12 Weeks After Stroke

scientific article published on 27 February 2012

Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice

scientific article published on 14 November 2019

Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity

scientific article published on 05 May 2019

Changes in Body Image in Patients with Prostate Cancer over 2 Years of Treatment with a Gonadotropin-Releasing Hormone Analogue (Triptorelin): Results from a Belgian Non-Interventional Study

scientific article published on 13 May 2016

Characterizing short stature by insulin-like growth factor axis status and genetic associations: results from the prospective, cross-sectional, epidemiogenetic EPIGROW study

scientific article published on 17 April 2013

Composite active range of motion (CXA) and relationship with active function in upper and lower limb spastic paresis

scientific article published on 26 April 2020

Control of IGF-I levels with titrated dosing of lanreotide Autogel over 48 weeks in patients with acromegaly

scientific article published on 31 January 2008

Correction to: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study

scientific article published on 01 December 2019

Correlations between spasticity, goal attainment, and global assessment of benefits in patients with upper limb spasticity treated with botulinum toxin A

scholarly article by Khashayar Dashtipour et al published December 2016 in Toxicon

Early AbobotulinumtoxinA (Dysport®) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study

scientific article published on 21 June 2018

Effect of early use of AbobotulinumtoxinA after stroke on spasticity progression: Protocol for a randomised controlled pilot study in adult subjects with moderate to severe upper limb spasticity (ONTIME pilot).

scientific article published on 14 February 2017

Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment

scientific article published on 28 February 2020

Evaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer

scientific article published on 4 April 2014

Factors and Regional Differences Associated with Endometriosis: A Multi-Country, Case-Control Study

scientific article published on 24 June 2016

Factors influencing goal attainment in patients with post-stroke upper limb spasticity following treatment with botulinum toxin A in real-life clinical practice: sub-analyses from the Upper Limb International Spasticity (ULIS)-II Study

scientific article published on 8 April 2015

Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study.

scientific article

Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia

scientific article published on 20 November 2014

How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study

scientific article published on 09 September 2019

INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin

scientific article published on 21 December 2017

Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).

scientific article published on 17 June 2016

Inappropriate citations used to describe the pharmacology of botulinum toxin type A preparations in clinical use

scientific article published on 01 June 2009

Inappropriate conclusions from the use of botulinum toxin for the treatment of spasticity

scientific article

Integrated upper limb spasticity management including botulinum toxin A (BoNT-A) on patient-centred goal attainment: Methodology for ULIS-III and initial goal-setting data

scholarly article by Lynne Turner-Stokes et al published December 2016 in Toxicon

Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study

scientific article

Lanreotide Autogel in the Treatment of Idiopathic Refractory Diarrhea: Results of an Exploratory, Controlled, Before and After, Open-label, Multicenter, Prospective Clinical Trial

scientific article published on 13 July 2016

Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study

scientific article published on 15 January 2016

Poster 182 Baseline Characteristics of Cervical Dystonia Subjects in Observational Routine-Practice Studies are Different to Those from Randomized Controlled Trials

scientific article published on 24 September 2016

Poster 187 Is There a Correlation Between Tremor and Other Symptoms of Cervical Dystonia? An Analysis of Data from the Ongoing INTEREST IN CD2 Study

scientific article

Poster 313 Relationship Between AbobotulinumtoxinA Injections into Shoulder Muscles and Patient Centred Primary Goal Selection and Achievement: Sub-Analyses from the Upper Limb International Spasticity (ULIS)-II Study

scientific article

Poster 373-C Integrated Upper Limb Spasticity Management Including Botulinum Toxin A (BoNT-A) on Patient-Centered Goal Attainment: Methodology for ULIS-III and Initial Goal-Setting Data.

scientific article

Poster 498 Geographic Differences in the Characteristics of Cervical Dystonia Patients

scientific article

Poster 57: Time to Retreatment with Botulinum Toxin A in Upper Limb Spasticity Management: Initial Data from the Upper Limb International Spasticity (ULIS)-III Study

Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.

scientific article published in May 2004

Randomized, placebo-controlled, double-blind study of the efficacy of lanreotide 30 mg PR in the treatment of pancreatic and enterocutaneous fistulae

scientific article published in December 2009

Relationship between abobotulinumtoxina injections into shoulder muscles and patient-centered primary goal selection and achievement: Subanalyses from the upper limb international spasticity (ULIS)-II study

scholarly article by Jorge Jacinto et al published December 2016 in Toxicon

Results from the Upper Limb International Spasticity Study-II (ULISII):a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management.

scientific article published on 20 June 2013

Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies

scientific article published on 9 July 2018

Survey of practices employed by neurologists for the definition and management of secondary non-response to botulinum toxin in cervical dystonia ⬇️

scientific article published on October 1, 2012

Symptomatic Treatment With Lanreotide Microparticles in Inoperable Bowel Obstruction Resulting From Peritoneal Carcinomatosis: A Randomized, Double-Blind, Placebo-Controlled Phase III Study ⬇️

scientific article published on October 29, 2012

The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type A: an international survey

scientific article published on September 2010

Time to retreatment with botulinum toxin A in upper limb spasticity management: Initial data from the Upper Limb International Spasticity (ULIS)-III study

Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly: results of a prospective multicenter clinical trial

scientific article

Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice

scientific article

Paulina is supported by:

About Paulina

Help